Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIV.
Burty
Christine
C
Prazuck
Thierry
T
Truchetet
Francois
F
Christian
Bernard
B
Penalba
Christian
C
Salmon-Ceron
Dominique
D
Yazdanpanah
Yazdan
Y
May
Thierry
T
Rabaud
Christian
C
D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000009:adverse effects; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control; D008297:Male; D016273:Occupational Exposure / Q000517:prevention & control*; D009786:Occupational Health Services; D063065:Organophosphonates / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use; D010349:Patient Compliance; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine